Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
NCT01241500
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
299
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndromes
MDS
RAEB
Chronic Myelomonocytic Leukemia
Interventions
DRUG:
ON 01910.Na
Sponsor
Traws Pharma, Inc.
Collaborators
[object Object]